TRENTON, NJ — Gov. Phil Murphy said Tuesday he expects the progress made so far in New Jersey's vaccine rollout to be given a much-needed push forward by the Biden administration once the President-elect is sworn in on Wednesday.

So far, the state has had to reckon with delays in the arrival of doses from the federal government and thus large segments of the population left waiting for their turn in line.

“We know that there is pent-up demand, that getting an appointment may be proving challenging. However, with the incoming Biden administration taking office tomorrow and a new federal focus on pushing vaccines out at a greater pace, we are hopeful that we'll be able to start ramping up our in-state capabilities to meet what we know is a tremendous demand,” Murphy said during a virtual update in Trenton on Tuesday. 

Sign Up for Bordentown Newsletter
Our newsletter delivers the local news that you can trust.

As of mid-morning Tuesday, New Jersey had administered 388,160 vaccinations at 130 sites statewide. The Governor said more than 100 “are coming online soon” but would not go into detail.

Over 50,000 of the 214,000 vaccine shots committed to long-term care facilities have been administered.

Speaking on how CVS and Walgreens, federal partners entrusted with part of the vaccine efforts, Murphy said, "They're working through their appointments, but they need to punch at a higher rate, especially Walgreens.”

Ten months into the pandemic, he extended the public health emergency for another 30 days - the eleventh time he’s done so.

Over a million people have pre-registered on the state’s vaccine site, officials said.

Health Commissioner Judy Persichilli said residents who got the first dose but have not received word about a second shot should contact the state. A hotline has been set up at 855-568-0545 in both English and Spanish, with a call center scheduled for launch next week.

“When more slots open up, we are asking the public to be patient because supply of vaccine is limited. It may be some time before you receive an invitation to make an appointment, even if you are currently eligible,” Persichilli said, a week after the state expanded those who qualified for priority.

“With the expansion of eligibility into more categories, there are now many more people who are eligible to get vaccinated but our vaccine supply is still very limited and will be for some time,” she continued.

At the moment the state is inoculating patients with either the Moderna or Pfizer vaccine, both of which require two doses. Towards the end of press conference, Murphy said the approval of the Johnson & Johnson vaccine - expected to just require one dose - would be a “game changer.”

At state nursing homes, 90 percent of patients have been scheduled for a vaccine and the same percentage are set to receive shots at intellectual or developmental disability centers and homes in the federal partnership program. Also, 74 percent of people at residential care facilities are scheduled, as well as 64 percent of residents at assisted-care facilities.

In December, however, Persichilli said New Jersey received 18 percent less of the shots they expected.

Late last year, Murphy said the state planned to vaccinate 70 percent of the adult population, or 4.5 million people.

In the first two weeks of January, New Jersey received 53,000 Pfizer shots and 53,000 Moderna shots. On Monday, Persichilli said she was informed that next week it will get another 55,575 Pfizer and 56,100 Moderna shots.

Dr. Eddy Bresnitz, medical advisor for the health department, addressed the latest on the new coronavirus strain.

Although it’s one of many variants, the mutation - first discovered in the U.K. - is notable for being more transmissible.

“It's now been reported in at least 20 states in the country but less than 100 cases as of last week…reported by the CDC,” said Bresnitz, noting that Delaware has at least one confirmed case. “So it's just a matter of time before New Jersey will report a case. We send samples down to the CDC on a regular basis for testing and our own laboratory is actually developing its own capabilities for doing that testing as well.”

“As the Governor mentioned, there's no evidence to date that it causes more severe disease, but because it's more easily transmissible we can expect that it will have an impact on the incidence of disease,” he added.

Bresnitz said New Jersey, like many other states in the U.S., is now in a race to get as many people vaccinated before the new COVID-19 mutation becomes the dominant one.

Follow us on Facebook and sign up for TAPinto Bordentown E-News alerts to be the first to read about all things local!

Download the FREE TAPinto App!  Click here for Android - Click here for iOS for breaking news, traffic/weather alerts and special offers.

Know a story we should share with readers? Email Editors Elizabeth Meyers and Kristin Antonello and tell them about it.